Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study

Abstract Background A new formulation of the live-attenuated varicella vaccine Varilrix (GSK) produced without human serum albumin (HSA) was developed to minimize a theoretical risk of transmission of infectious diseases. A previous study showed that the vaccine was immunologically non-inferior to t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Saul N. Faust (Author), Maguelone Le Roy (Author), Chitsanu Pancharoen (Author), Miguel Angel Rodriguez Weber (Author), Katrina Cathie (Author), Ulrich Behre (Author), Jolanta Bernatoniene (Author), Matthew D. Snape (Author), Klaus Helm (Author), Carlos Eduardo Medina Pech (Author), Ouzama Henry (Author), Carmen Baccarini (Author), Michael Povey (Author), Paul Gillard (Author)
Formato: Libro
Publicado: BMC, 2019-02-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Dispoñible